Related references
Note: Only part of the references are listed.Aflibercept
Michael W. Stewart et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Furin Processing of Semaphorin 3F Determines Its Anti-Angiogenic Activity by Regulating Direct Binding and Competition for Neuropilin
Matthew W. Parker et al.
BIOCHEMISTRY (2010)
A Forward Genetic Screen in Mice Identifies Sema3AK108N, which Binds to Neuropilin-1 but Cannot Signal
Janna Merte et al.
JOURNAL OF NEUROSCIENCE (2010)
A Mutated Soluble Neuropilin-2 B Domain Antagonizes Vascular Endothelial Growth Factor Bioactivity and Inhibits Tumor Progression
Elena Geretti et al.
MOLECULAR CANCER RESEARCH (2010)
The role of neuropilins in cell signalling
Ian C. Zachary et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2009)
Expression of SEAP (secreted alkaline phosphatase) by baculovirus mediated transduction of HEK 293 cells in a hollow fiber bioreactor system
B. A. Jardin et al.
JOURNAL OF BIOTECHNOLOGY (2008)
Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF165 binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex
Anna Starzec et al.
PEPTIDES (2007)
Site-directed mutagenesis in the b-neuropilin-2 domain selectively enhances its affinity to VEGF165, but not to semaphorin 3F
Elena Geretti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Structural basis for ligand and heparin binding to neuropilin B domains
Craig W. Vander Kooi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord
Shinjiro Kaneko et al.
NATURE MEDICINE (2006)
A time- and cost-efficient system for high-level protein production in mammalian cells
A. Radu Aricescu et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2006)
Chemorepellent axon guidance molecules in spinal cord injury
SP Niclou et al.
JOURNAL OF NEUROTRAUMA (2006)
Overcoming inhibition in the damaged spinal cord
JW Fawcett
JOURNAL OF NEUROTRAUMA (2006)
In vitro and in vivo characterization of a novel semaphorin 3A inhibitor, SM-216289 or xanthofulvin
K Kikuchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Role of semaphorins in the adult nervous system
J de Wit et al.
PROGRESS IN NEUROBIOLOGY (2003)
Meningeal cell-derived semaphorin 3A inhibits neurite outgrowth
SP Niclou et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2003)
VEGF-Trap: A VEGF blocker with potent antitumor effects
J Holash et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
New insights into binding interfaces of coagulation factors V and VIII and their homologues - Lessons from high resolution crystal structures
P Fuentes-Prior et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2002)
Characterization of neuropilin-1 structural features that confer binding to semaphorin 3A and vascular endothelial growth factor 165
CH Gu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Injury-induced class 3 semaphorin expression in the rat spinal cord
F De Winter et al.
EXPERIMENTAL NEUROLOGY (2002)
A model for gene therapy of human hereditary lymphedema
MJ Karkkainen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor:: In vivo expression and antitumor activity
ML Gagnon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
